鷺燕醫藥(002788.SZ):四家子(孫)公司註銷登記已辦理完畢
格隆匯12月11日丨鷺燕醫藥(002788.SZ)公佈,公司於2019年8月16日召開第四屆董事會第十四次會議審議通過了《關於註銷公司子公司的議案》,同意註銷公司全資子(孫)公司福建省鷺燕耀升生物醫藥有限公司、福州市博研生物醫藥有限公司、福州富利達生物醫藥有限公司和控股子公司福建海天藍生物製品有限公司等四家公司。
2019年11月,公司完成子公司福州市博研生物醫藥有限公司、福建省鷺燕耀升生物醫藥有限公司、福建海天藍生物製品有限公司的註銷登記)。
近日,公司收到了閩侯縣市場監督管理局出具的《准予註銷登記通知書》【(侯)登記內注核字[2019]第9419號】,准予公司孫公司福州富利達生物醫藥有限公司的註銷登記。
截至公告披露日,上述四家子(孫)公司的註銷登記已辦理完畢。
由於上述四家子(孫)公司已完成註銷,公司合併財務報表的範圍將相應發生變化,但不會對公司的正常經營活動、整體業務發展和盈利水平產生重大影響,亦不會損害公司及股東利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.